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SUMMARY
Objectives: The aim of this study was to investigate annual and seasonal trends in mortality rates from cardiovascular diseases in Hungary 
between 1984 and 2013.
Methods: Annual and monthly mortality and population data were obtained from the Hungarian Central Statistical Office. The annual mortality 
data by gender and age were available for the following disease classifications of the circulatory system: all cardiovascular diseases, all diseases 
of the heart, hypertension, coronary heart disease, and cerebrovascular diseases. Six age groups were defined for both sexes. Negative binomial 
regression was carried out to analyse annual trends in age-standardized mortality rates. The Walter-Elwood method was used to identify seasonal 
variation using monthly numbers of deaths.
Results: Significant decreases in annual mortality rates for all cardiovascular diseases were found, but not for hypertension. Age-standardized 
death rates were higher for men for all causes, except for hypertension. The greatest sex difference in the average risk of death was observed in 
the middle-aged groups. The greatest percentage decrease in death rates during the study period was seen for both sexes in the under 35 age 
group. The lowest percentage change was observed among people aged over 75. Significant seasonality was found in monthly death rates from 
all causes, with a peak in February.
Conclusions: In spite of a decreasing trend in the annual mortality rates for cardiovascular diseases, the Hungarian mortality rate is still high. 
Moreover, this study demonstrated a significant winter peak in mortality from cardiovascular diseases over a thirty-year period.
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INTRODUCTION
Despite declines in mortality rates in most European coun-
tries, cardiovascular diseases are still the most common causes 
of death in Europe and are responsible for 45% of all deaths 
(1). Similarly, cardiovascular diseases are the leading causes 
of death in Hungary in spite of the fact that decreasing death 
rates have been seen for the last three decades. Hungarian car-
diovascular mortality rates are ranked high among countries in 
the European Union (1). In 2013, 49.7% of deaths were caused 
by cardiovascular diseases (2). Of the total number of 62,979 
deaths from all cardiovascular diseases, 73.7% were caused by 
heart disease and 20.4% by cerebrovascular disease. The most 
common types of heart disease are ischaemic heart disease and 
hypertension (69.1% and 16.4% of all diseases of the heart, 
respectively). The aim of this study was to describe the sea-
sonal and annual trends in age-standardized death rates from 
cardiovascular diseases over the last thirty years in Hungary.
MATERIALS AND METHODS
The Hungarian monthly and annual mortality data for cardio-
vascular diseases and the annual mid-year population estimates 
for the 1984–2013 period were provided by the Hungarian Central 
Statistical Office (2). The underlying causes of death were clas-
sified according to the International Classification of Diseases, 
Ninth and Tenth Revisions. The ICD-10 codes used were I00-I99 
for all diseases of the circulatory system, I00-I51 for all diseases 
of the heart, I10-I15 for hypertension, I20-I25 for coronary heart 
disease, and I60-I69 for cerebrovascular diseases.
Annual Trends
Death rates are expressed per 100,000 population using the 
annual mid-year population estimates for the relevant year. 
Age-standardized death rates were calculated for all causes 
by direct standardization to the European standard population 
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(3). Time trends in annual age-standardized death rates from 
1984 to 2013 were assessed by negative binomial regression 
analysis. Twelve age- and sex-specific groups were defined: 
ages under 35, 35–44, 45–54, 55–64, 65–74, and over 75. An-
nual percentage changes (APC), standardized rate ratios and 
95% confidence intervals (CI) associated with gender and age 
were estimated (4, 5). Interaction terms were included in the 
negative binomial regression models to obtain age- and sex-
specific mortality estimates.
Seasonal Trends
Cyclic trends in aggregated monthly data on deaths from car-
diovascular diseases were investigated with the Walter-Elwood 
method, which takes into account the underlying population 
at risk (6, 7). Monthly deaths were adjusted for month length. 
Monthly population estimates were calculated based on the 
monthly number of births and deaths provided by the Hungarian 
Central Statistical Office. Winter-to-summer ratios for all causes 
of death were calculated as the total deaths in January, February 
Men (95% CI) Women (95% CI) Men to women standardized  rate ratio (95% CI)
All cardiovascular diseases a
1984–1988 775.97 (772.45–779.51) 514.52 (512.23–516.82) 1.51 (1.50–1.52)
1989–1993 764.84 (761.33–768.35) 496.83 (494.60–499.06) 1.54 (1.53–1.55)
1994–1998 721.65 (718.23–725.08) 472.85 (470.71–474.99) 1.53 (1.52–1.54)
1999–2003 629.38 (626.29–632.48) 407.86 (405.96–409.77) 1.54 (1.53–1.55)
2004–2008 576.17 (573.29–579.06) 362.10 (360.38–363.84) 1.59 (1.58–1.60)
2009–2013 506.80 (504.17–509.44) 331.20 (329.60–332.80) 1.53 (1.52–1.54)
All diseases of the heart b
1984–1988 429.98 (427.36–432.61) 253.80 (252.17–255.43) 1.69 (1.68–1.71)
1989–1993 441.66 (439.00–444.33) 258.86 (257.24–260.49) 1.71 (1.69–1.72)
1994–1998 435.05 (432.40–437.71) 262.50 (260.90–264.11) 1.66 (1.64–1.67)
1999–2003 388.21 (385.79–390.65) 235.28 (233.83–236.73) 1.65 (1.64–1.66)
2004–2008 408.14 (405.72–410.58) 248.45 (247.02–249.88) 1.64 (1.63–1.66)
2009–2013 374.36 (372.10–376.63) 240.45 (239.09–241.81) 1.56 (1.54–1.57)
Coronary heart disease c
1984–1988 321.78 (319.51–324.06) 160.90 (159.61–162.21) 2.00 (1.98–2.02)
1989–1993 330.13 (327.83–332.44) 169.52 (168.21–170.84) 1.95 (1.93–1.97)
1994–1998 331.60 (329.28–333.92) 184.13 (182.79–185.47) 1.80 (1.78–1.82)
1999–2003 294.00 (291.89–296.12) 170.44 (169.21–171.67) 1.72 (1.71–1.74)
2004–2008 301.45 (299.37–303.54) 176.74 (175.54–177.94) 1.71 (1.69–1.72)
2009–2013 268.44 (266.52–270.36) 164.16 (163.05–165.28) 1.64 (1.62–1.65)
Hypertension d
1984–1988 39.16 (38.37–39.95) 44.36 (43.70–45.03) 0.88 (0.86–0.91)
1989–1993 41.50 (40.69–42.33) 43.41 (42.76–44.07) 0.96 (0.93–0.98)
1994–1998 33.96 (33.22–34.71) 35.58 (35.00–36.17) 0.95 (0.93–0.98)
1999–2003 32.71 (32.01–33.42) 30.39 (29.88–30.91) 1.08 (1.05–1.11)
2004–2008 41.49 (40.72–42.27) 35.85 (35.31–36.39) 1.16 (1.13–1.19)
2009–2013 44.50 (43.72–45.28) 40.12 (39.57–40.67) 1.11 (1.08–1.13)
Cerebrovascular diseases e
1984–1988 211.59 (209.76–213.44) 159.97 (158.69–161.26) 1.32 (1.31–1.34)
1989–1993 198.55 (196.77–200.35) 144.39 (143.19–145.60) 1.38 (1.36–1.39)
1994–1998 184.49 (182.76–186.22) 132.39 (131.25–133.53) 1.39 (1.38–1.41)
1999–2003 165.72 (164.14–167.31) 114.59 (113.58–115.60) 1.45 (1.43–1.47)
2004–2008 125.61 (124.27–126.96) 85.03 (84.19–85.88) 1.48 (1.46–1.50)
2009–2013 102.86 (101.68–104.05) 71.45 (70.70–72.20) 1.44 (1.42–1.46)
a ICD-10 codes I00-I99, b ICD-10 codes I00-I51, c ICD-10 codes I20-I25, d ICD-10 codes I10-I13, e ICD-10 codes I60-I69
Table 1. Age-standardized mortality rates (per 100,000 population) for cardiovascular diseases by gender in Hungary between 
1984 and 2013
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and March divided by the total number of deaths in July, August 
and September.
Values of p less than 0.05 were considered statistically signifi-
cant. All analyses were performed with the Stata 13 software (8).
RESULTS
Overall Annual Trends
Between 1984 and 2013, the age-standardized death rate (per 
100,000 population) from all cardiovascular diseases in Hungary 
decreased by 40.6% from 675 to 401 based on the European 
standard population. The greatest percentage decreases during 
this interval were in death rates from cerebrovascular disease 
(59.3% from 199 to 81). Death rates decreased by 16.1% from 
353 to 296 for heart diseases, dropped by 15.6% from 244 to 206 
for ischaemic heart disease, and increased by 11.1% from 41 to 
45 for hypertension.
The age-standardized death rates from all causes were higher 
for men from 1984 to 1998 except for hypertension (Table 1).
When age-standardized annual mortality rates were exam-
ined using negative binomial regression analyses, significantly 
decreasing trends were observed for all causes but hypertension.
Annual Trends by Gender
When death rates were examined by gender, negative binomial 
regression analyses showed significantly decreasing trends for 
both males and females for all cardiovascular diseases (Table 
2). Similarly, significantly declining trends were observed for 
all heart diseases and for cerebrovascular diseases. For coronary 
heart disease, annual mortality rates decreased significantly for 
men and increased non-significantly for women. Mortality rates 
from hypertension increased non-significantly for males and 
decreased significantly for females.
The average risk of death for males was 1.54 times higher (95% 
CI = 1.534–1.545) than for females for cardiovascular diseases, 1.65 
times higher (95% CI = 1.636–1.668) for heart diseases, 1.80 times 
higher (95% CI = 1.755–1.849) for coronary heart disease, 1.02 
times higher (95% CI = 0.983–1.058) for hypertension, and 1.41 
times higher (95% CI = 1.391–1.429) for cerebrovascular diseases.
Annual Trends by Gender and Age
Age-standardized death rates increased with age among both 
men and women for all cardiovascular diseases under examina-
tion. For all causes other than hypertension, significantly decreas-
ing trends were observed in annual mortality rates for both sexes 
and for most age groups (Fig. 1). The greatest percentage decrease 
Men Women
APC 95% CI p-value APC (%) 95% CI p-value
All cardiovascular diseases −1.73% −1.91, −1.55 < 0.001 −1.84 −2.05–1.63 < 0.001
All heart diseases −0.59% −0.79, −0.39 < 0.001 −0.29 −0.55–0.03 0.029
Cerebrovascular diseases −2.70% −3.01, −2.38 < 0.001 −3.09 −3.47,−2.71 0.001
Coronary heart disease −0.73% −0.96, −0.49 < 0.001 0.07 −0.25–0.38 0.679
Hypertension 0.38% −0.28, −1.05  0.261 −0.74 −1.40–0.07 0.029
Table 2. Annual trends for all cardiovascular diseases, all heart diseases, coronary heart disease, hypertension, and cerebro-
vascular diseases by gender in Hungary between 1984 and 2013
Fig. 1a All cardiovascular diseases, men. Fig. 1b All cardiovascular diseases, women.
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Fig. 1c All diseases of the heart, men. Fig. 1d All diseases of the heart, women.
Fig. 1e Coronary heart disease, men. Fig. 1f Coronary heart disease, women.
Fig. 1g Hypertension, men. Fig. 1h Hypertension, women.
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Fig. 1i Cerebrovascular diseases, men. Fig. 1j Cerebrovascular diseases, women.
during the study period was seen in the under 35 age group for 
both men and women, with a percentage decrease of 4.30% (95% 
CI = −5.88, −2.70; p < 0.001) and 4.60% (95% CI = −6.18, −3.00; 
p < 0.001) for cardiovascular diseases; 4.20% (95% CI = −6.06, 
−2.29; p < 0.001) and 4.35% (95% CI = −6.23, −2.44; p < 0.001) 
for heart diseases; 6.66% (95% CI = −9.47, −3.77; p < 0.001) and 
6.46% (95% CI = −9.29, −3.54; p < 0.001) for coronary heart dis-
ease; and 5.00% (95% CI = −8.35, −1.54; p = 0.005) and 5.54% 
(95% CI = −8.86, −2.09; p = 0.002) for cerebrovascular diseases. 
The lowest percentage change was observed for both men and 
women in the over 75 age group, with a percentage decrease 
of 1.09% (95% CI = −1.30, −0.88; p < 0.001) and 1.40% (95% 
CI = −1.62, −1.18; p < 0.001) for cardiovascular diseases; and 
2.05% (95% CI = −2.46, −1.64; p < 0.001) and 2.60% (95% CI 
= −3.02, −2.17; p < 0.001) for cerebrovascular diseases; as well 
as percentage increase of 0.73% (95% CI = 0.45–1.02; p < 0.001) 
and 0.57% (95% CI = 0.27–0.86; p < 0.001) for heart diseases; 
and 0.86% (95% CI = 0.53–1.20; p < 0.001) and 1.08% (95% CI 
= 0.73–1.44; p < 0.001) for coronary heart disease. Trends in hy-
pertension mortality data were not significant except for men over 
75 (APC = 1.30%, 95% CI = 0.47–2.14, p = 0.002) and women 
aged 55–64 (APC = −1.97%, 95% CI = −3.41, −0.51, p = 0.008) 
and 65–74 (APC = −2.05%, 95% CI = −3.12, −0.96; p < 0.001).
On average, the risk of death from hypertension for males 
was higher than that for females in all age categories, except for 
the oldest group. For cardiovascular diseases, heart diseases and 
coronary heart diseases, the lowest rate was seen among people 
aged over 75 years, and the highest was observed in the 45–54 
age group. The average ratio of men to women varied from 1.13 
(95% CI = 1.113–1.137) to 3.11 (95% CI = 3.078– 3.143) for car-
diovascular diseases; from 1.14 (95% CI = 1.130–1.143) to 3.65 
(95% CI = 3.625–3.665) for heart disease; and from 1.22 (95% 
CI = 1.214–1.232) to 4.27 (95% CI = 4.242–4.303) for coronary 
heart disease. For hypertension, the ratio of men to women ranged 
from 0.77 (95% CI = 0.738–0.808, aged over 75 years) to 2.14 
(95% CI = 2.042–2.236, aged under 35 years). The average men-
to-women risk ratio for cerebrovascular death is the largest for 
those aged 55–64 (2.24, 95% CI = 2.203–2.286) and the lowest in 
the oldest age group with a value of 1.11 (95% CI = 1.087–1.128). 
Seasonal Trends
The Walter-Elwood tests on aggregated monthly mortality data 
indicate significant evidence of seasonality for all cardiovascular 
diseases under examination (p < 0.001). Mortality rates are highest 
during winter (in January and February) and lowest during late 
summer (in August and September). The winter-to-summer ratio 
varied from 1.24 (cerebrovascular diseases) to 1.28 (hyperten-
sion). The Walter-Elwood tests showed a maximum estimated 
mortality rate in February for all diseases (Fig. 2).
DISCUSSION
Main Findings
Significant decreases in annual mortality rates for all car-
diovascular, heart and cerebrovascular diseases were found in 
Hungary between 1984 and 2013. However, age-standardized 
death rates for hypertension did not show a clear trend during 
this period. Similar trends were observed among male and female 
annual mortality rates for all cardiovascular and cerebrovascular 
diseases, but not for all heart diseases, ischaemic heart disease and 
hypertension. Annual mortality rates did not change significantly 
for ischaemic heart disease among women and for hypertension 
among men. The greatest percentage decrease in death rates 
during the study period was seen for both sexes in the under 35 
age group. The lowest percentage change was observed among 
those aged over 75. The greatest sex difference in the average 
risk of death was detected in the middle-aged groups. Significant 
seasonality was found in monthly death rates from all causes, 
with a peak in February.
Fig. 1. Annual trends in standardized mortality rates for all cardiovascular diseases, all heart diseases, coronary heart disease, 
hypertension and cerebrovascular diseases in Hungary between 1984 and 2013.
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Fig. 2. Seasonal variations in monthly mortality rates for all cardiovascular diseases, all heart diseases, coronary heart disease, 
hypertension and cerebrovascular diseases in Hungary between 1984 and 2013.
Fig. 2a All cardiovascular diseases. Fig. 2b All diseases of the heart.
Fig. 2c Coronary heart disease. Fig. 2d Hypertension.
Fig. 2e Cerebrovascular diseases.
Strengths and Weaknesses of the Study
Our population data were obtained from published tables. 
However, a long study period of 30 years was used in the analy-
ses, allowing us to investigate trends in mortality rates. Our data 
were obtained from civil registers. In spite of the fact that the 
mortality data was coded according to the World Health Organi-
zation recommendations, these data could have been influenced 
by a simplified method of the categorization and by differences 
in two ICD revisions that were implemented in Hungary during 
the study period. Additionally, minor changes occurred in the 
structure of reported data during the thirty-year interval of the 
study. To accommodate these circumstances, we examined broad 
disease categories with negative binomial regression analyses. 
Overdispersion did not influence our results as the negative bi-
nomial regression method was used in both risk estimation and 
investigation of the annual mortality trend.
In the monthly cyclic trend analyses, we used the Walter-
Elwood method with a long study period.
Data on mortality for hypertension were available as cause of 
death. Thus, hypertension was examined as the underlying cause 
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of death, but high blood pressure can contribute to other cardio-
vascular diseases (comorbidity). However, we were not able to 
separate these effects based on the available data.
Comparison with Other Studies
Townsend et al. (1) reported that the age-standardized mortality 
rate from cardiovascular disease has decreased in most European 
countries during the past few decades. Rahimi et al. (9) concluded 
that myocardial infarction, ischaemic heart disease and heart 
failure mortality rates have been declining in England. Ma et al. 
(10) also found decreasing trends in age-standardized death rates 
from stroke and heart disease in the United States. Backholer et 
al. (11) reported declining age-standardized circulatory disease 
mortality rates in Australia. Like those studies, we found that 
cardiovascular death rates decreased significantly in Hungary 
during the thirty-year study period. However, Hungarian mortality 
rates were higher than the Western European rates (1). Hungarian 
mortality rates for all cardiovascular diseases are similar to those 
in Slovakia (12), but in contrast with those findings, the standard-
ized mortality rate for ischaemic heart disease has decreased for 
men in Hungary. In agreement with our results, Vujcic et al. (13) 
observed significantly decreasing trends in coronary heart disease 
mortality rates among men, but not among women. Although no 
data was available on morbidity for cardiovascular diseases in 
Hungary, Bandosz et al. (14) reported that the fall in mortality 
from coronary heart disease in Poland can be attributed to reduc-
tions in major risk factors and that about one-third of this drop 
results from evidence-based medical treatments. The decreasing 
Hungarian mortality rates for cardiovascular disease were simi-
larly explained in a review study by Bálint (15).
In spite of the decreasing trend in age-adjusted cardiovascular 
disease mortality in Western European countries, an increase 
in the number of cardiovascular patients is expected because 
of population ageing (1). Although age-standardized rates for 
stroke mortality have decreased worldwide in the past two de-
cades, according to the Global Burden of Disease Study 2013, 
the absolute numbers of people who suffer a stroke every year 
are increasing (16).
In a study by Aylin et al. (17), a strong inverse association 
with temperature was reported in Great Britain and a trend of 
higher excess winter mortality with age was observed across all 
disease categories. Thus, the effects of cold weather are usually 
most apparent in mortality due to cardiovascular and respiratory 
diseases as well as in the elderly. Similarly, chronic heart failure 
deaths in France occurred with a striking annual periodicity 
and peaked in winter (December through January) (18). In a 
population-based study in Scotland between 1990 and 1996, 
Stewart et al. reported a significant seasonal variation in mortal-
ity among patients whose hospitalization was tied to heart failure 
(19). The peak was observed in December. Furthermore, a winter 
peak seasonality in cardiovascular disease deaths was reported in 
Australian State and Territory capitals between 1997 and 2004 
(20). Major influences of seasonal change were also seen in heart 
and cerebrovascular diseases in a thirty-year study in Japan, with 
the highest rates in winter (21). A review of thirty-nine studies 
indicated that influenza can act as a trigger for acute myocardial 
infarction and cardiovascular death (22). Similarly, our findings 
suggest that the significant peaks in cardiovascular, heart and 
cerebrovascular mortality could be related to respiratory infec-
tions at the end of winter. Besides seasonal viral infections, excess 
winter mortality can be attributed to environmental factors such 
as temperature, air pollution, lifestyle factors (23), and seasonal 
changes in cardiovascular risk factor levels (24).
Cold-related mortality has been comprehensively examined 
in Western Europe, but there have been few studies conducted in 
Central European populations. Our study used a relatively long, 
thirty-year period to investigate both annual and seasonal trends in 
mortality from cardiovascular (heart and cerebrovascular) diseases.
CONCLUSION
In this study, a number of risk factors and trends were investi-
gated in relation to cardiovascular mortality using well-established 
statistical methods. In spite of the decreasing trends in the annual 
mortality rates for cardiovascular diseases, the Hungarian mor-
tality rate is still high. Moreover, this study has demonstrated a 
significant winter peak in mortality from cardiovascular diseases. 
The identification of groups at higher risk may be important for 
disease prevention. 
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